Drug profile · INN
binimetinib
MEKTOVI
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
binimetinib (MEKTOVI) is an FDA-listed pharmaceutical active ingredient. Associated with Pierre Fabre Australia Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN binimetinib
Brand MEKTOVI
Route ORAL
Formulation TABLET
ATC code L01EE03
Originator Pierre Fabre Australia Pty Ltd
Frequently asked questions
What is binimetinib?
binimetinib (MEKTOVI) is an FDA-listed pharmaceutical active ingredient. Associated with Pierre Fabre Australia Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for binimetinib?
MEKTOVI is a marketed brand name for binimetinib. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of binimetinib?
binimetinib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.